Caxton Associates LP Zoetis Inc. Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Zoetis Inc. stock. As of the latest transaction made, Caxton Associates LP holds 5,501 shares of ZTS stock, worth $966,360. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,501

Holding current value

$966,360

% of portfolio

0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $949,362 - $1.08 Million	5,501 New	5,501 $1.07 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $1.67 Million - $2.02 Million	10,106 New	10,106 $1.71 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $1.77 Million - $2.04 Million	10,973 New	10,973 $1.89 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $257,952 - $309,743	-1,967 Reduced 20.64%	7,564 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $745,453 - $917,678	5,027 Added 111.61%	9,531 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $459,487 - $589,465	2,946 Added 189.09%	4,504 $774,000
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $79,267 - $102,271	437 Added 38.98%	1,558 $294,000
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $217,126 - $276,920	1,121 New	1,121 $274,000
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $222,882 - $247,402	-1,419 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$137.1 - $165.37 $194,544 - $234,660	1,419 New	1,419 $235,000
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $295,678 - $462,503	-3,191 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $370,953 - $425,200	3,191 New	3,191 $422,000
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $419,060 - $488,775	-4,277 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $26,833 - $33,120	-329 Reduced 7.14%	4,277 $431,000
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $277,876 - $333,921	-3,505 Reduced 43.21%	4,606 $394,000
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $677,268 - $756,188	8,111 New	8,111 $743,000
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $246,636 - $283,920	-3,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $232,947 - $255,060	3,900	3,900 $249,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

Vanguard Group Inc Valley Forge, PA

41.2M
Shares

$7.25 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

36.8M
Shares

$6.47 Billion
0.15% of portfolio
State Street Corp Boston, MA

19.8M
Shares

$3.47 Billion
0.16% of portfolio
State Farm Mutual Automobile Insurance CO Bloomington, IL

16M
Shares

$2.82 Billion
2.73% of portfolio
Alliancebernstein L.P. New York, NY

15.4M
Shares

$2.7 Billion
1.05% of portfolio

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account